Skip to main content
Premium Trial:

Request an Annual Quote

GNS Healthcare Nets SAIC Contract to Analyze NCI's Drug Interaction Data


GNS Healthcare said this week that it has signed a subcontract with SAIC-Frederick to create in silico simulations of drug interaction data generated by applying several well-known cancer treatments to the National Cancer Institute's NCI-60 cancer cell line panel.

Financial terms of the agreement were not disclosed.

GNS said that in the first phase of the project, it will use its Reverse Engineering and Forward Simulation platform to build computer models from transcriptional profiling data previously collected by NCI from the application of several drugs to the panel.

The list of drugs includes doxorubicin X2, Millennium Pharmaceuticals' Velcade (bortezimib), paclitaxel, Bristol-Myers Squibb's Sprycel (dasatinib), Pfizer's Sutent (sunitinib), and Wyeth's Rapamycin.

The simulations are expected to provide insights into key genetic and molecular mechanisms of drug efficacy and resistance in cancer by connecting drug doses to transcriptional networks to endpoints, GNS said.

GNS also plans to build versions of the computer models that may be made available more broadly to cancer scientists for their own research via a web interface.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.